Rhythm Pharmaceuticals (RYTM) Tax Provisions (2021 - 2025)
Historic Tax Provisions for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Q3 2025 value amounting to $111000.0.
- Rhythm Pharmaceuticals' Tax Provisions rose 13226.74% to $111000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $438000.0, marking a year-over-year decrease of 3282.21%. This contributed to the annual value of $346000.0 for FY2024, which is 3865.25% down from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Tax Provisions stood at $111000.0 for Q3 2025, which was up 13226.74% from $337000.0 recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Tax Provisions registered a high of $22.0 million during Q1 2021, and its lowest value of -$9.0 million during Q3 2021.
- In the last 4 years, Rhythm Pharmaceuticals' Tax Provisions had a median value of $153500.0 in 2023 and averaged $787250.0.
- As far as peak fluctuations go, Rhythm Pharmaceuticals' Tax Provisions crashed by 19347.83% in 2024, and later skyrocketed by 13226.74% in 2025.
- Over the past 4 years, Rhythm Pharmaceuticals' Tax Provisions (Quarter) stood at -$9.0 million in 2021, then soared by 102.18% to $196000.0 in 2023, then crashed by 145.92% to -$90000.0 in 2024, then soared by 223.33% to $111000.0 in 2025.
- Its last three reported values are $111000.0 in Q3 2025, $337000.0 for Q2 2025, and $80000.0 during Q1 2025.